Background. Infections and autoimmune disorders are more frequent in Down syndrome, suggesting abnormality of adaptive immunity. Although the role of B cells and antibodies is well characterized, knowledge regarding T cells is limited.
Down syndrome is the most frequent genetic aberration, with an incidence of 1 in 800 births. Owing to improved medical care, life expectancy improved appreciably over the last 50 years [1, 2] . Apart from anatomic and structural abnormalities, a characteristic feature of Down syndrome is its association with an increased susceptibility for respiratory infections, altered vaccine response, and increased incidence of autoimmune disorders and leukemia, resulting in higher hospitalization and mortality rates [3] [4] [5] [6] [7] [8] .
The clinical features associated with Down syndrome are indicative of an immune dysregulation, and several studies have been conducted to identify and characterize the underlying immunodeficiency in more detail. Alterations in adaptive immunity were observed which are reminiscent of immunosenescence typically seen in the elderly, which are characterized by a lack of diversity among naive cells and an altered development of terminally differentiated cells [9] [10] [11] [12] . Moreover, humoral immune responses after vaccination were found to be altered [13] [14] [15] , presumably owing to a lower number of switched memory B cells [13] . Finally, a higher apoptotic potential of cells and an increase in proinflammatory cytokine production are considered responsible for a more severe course of infections [16] [17] [18] .
Up to now, the characterization of immunity in individuals with Down syndrome mainly focused on the quantitative analysis of lymphocyte subpopulations and functional analysis of B cells and humoral immunity, whereas knowledge on T-cell subpopulations and effector T-cell functionality is limited. In the current study, we therefore performed a quantitative and qualitative analysis of lymphocyte subpopulations. Moreover, polyclonally stimulated effector T cells and pathogen-specific T cells were characterized phenotypically and functionally and correlated with humoral immunity.
MATERIALS AND METHODS

Study Population and Sampling
We recruited 91 subjects, including 40 children, adolescents and young adults with cytogenetically confirmed trisomy 21 (mean age [standard deviation], 7.38 [1.11] years; 3 subjects >18 years old) and 51 immunocompetent controls matched for age and sex (8.80 [0.97] years; 5 subjects >18 years old; Table  1 ) during inpatient or outpatient treatment at the Department of Pediatrics and Neonatology and Department of Pediatric Cardiology (Saarland University hospital). Controls were fully immunocompetent individuals without chronic diseases. Individuals with serious infections were excluded. History of VZV infection and VZV vaccination as well as minor respiratory infections at the time of blood sampling were recorded using a parental questionnaire. Furthermore, autoimmune disorders and congenital heart defects, including their corrective surgical treatment, which often led to thymectomy, were documented.
Heparinized blood samples were collected as part of routine venipuncture, in part during elective surgery/cardiac catheterizations. All samples were stored at 4°C and processed within 24 hours. Because the available blood volume was limited in some younger children, not all analyses could be performed in these individuals. The study was approved by the local ethics committee (No. 214/14), and written informed consent was obtained from all individuals and their parents or legal guardians if subjects were <18 years old or under legal guardianship.
Quantification and Characterization of Lymphocyte Subpopulations
Lymphocyte subpopulations (natural killer [NK] cells, B cells, and CD4 + , CD8 + , and regulatory T cells) were characterized from 100 μL of whole blood that was stained with fluorochrome-labeled antibodies to CD3, CD4, CD8, CD56, CD16, CD19, CD25, CD127, and programmed cell death 1 (PD-1) (all from BD). After 20 minutes of incubation, samples were treated with lysing solution (BD). Subsequently, cells were washed with fluorescence-activated cell sorting buffer (phosphate-buffered saline, 5% filtered fetal calf serum, 0.5% bovine serum albumin, 0.07% sodium azide), and processed for analysis by means of flow cytometry (FACSCanto II system) and FACSDiva software, version 6.1.3 (BD).
Stimulation of Antigen-Specific CD4 + and CD8 + T Cells From Whole Blood
To analyze the cellular immune function and T-helper cell subpopulations (T-helper [Th] 1, Th2, and Th17), 300 μL of blood was stimulated polyclonally with 2.5 µg/mL Staphylococcus aureus enterotoxin B (SEB; Sigma). Moreover, antigen-specific stimulations were carried out with antigen lysates derived from cells infected with cytomegalovirus (CMV) or varicella-zoster virus (VZV; 32 µL/mL; Virion/Serion) as described before [19, 20] . Stimulation with uninfected cell lysate (32 µL/mL; Virion/ Serion) served as negative control. Detection limits of 0.05% and 0.02% reactive T cells were used for CMV-and VZV-reactive T cells, respectively, as defined elsewhere [19, 20] .
All stimulations were performed in the presence of costimulatory antibodies anti-CD28 and anti-CD49d (both 1 μg/mL; BD). After 2 hours of incubation at 37°C and 6% carbon dioxide, 10 µg/mL brefeldin A (Sigma) was added to inhibit secretion of cytokines. After another 4 hours of incubation, cells were fixed with lysing solution, and 2 samples per stimulus were immunostained with different mixtures of fluorochrome-labeled antibodies to CD4, CD8, CD69, interferon (IFN) γ, interleukin 2, 4, and 17 (IL-2, IL-4, IL-17), tumor necrosis factor (TNF) α, cytotoxic T-lymphocyte associated protein 4 (CTLA-4), and PD-1 (all BD) and analyzed by means of flow cytometry.
Quantification of Antigen-Specific Antibodies
Specific antibody levels were analyzed using a quantitative CMV and VZV immunoglobulin (Ig) G enzyme-linked immunosorbent assay, according to the manufacturer's instructions (Euroimmun).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software, version 5.02 (GraphPad). To compare continuous variables between 2 groups, the nonparametric Mann-Whitney test or the unpaired t test were used. Significant differences of categorical variables were calculated with the Fisher exact test, and correlation was analyzed using κ statistics [21] . Differences were considered significant at P < .05.
RESULTS
Study Population
Forty individuals with Down syndrome (37 children and adolescents <18 years of age, 3 young adults), and 51 controls were included in the study. The individuals were matched for age and sex and had similar VZV vaccination and VZV infection status. Moreover, the percentages of individuals with acute mild respiratory infections at the time of analysis did not differ. As expected for children with Down syndrome, congenital heart defects, the need for an open-heart surgery, and a partial or complete resection of the thymus were more frequent than in controls (Table 1) .
Alterations in Lymphocyte Subpopulations in Individuals With Down
Syndrome
We first analyzed the distribution of leukocyte subpopulations from blood samples of individuals with Down syndrome and controls using flow cytometry (Figure 1 ). Among bulk populations of leukocytes defined by forward-and side-scatter properties, no differences were observed in the percentages of monocytes, granulocytes, or lymphocytes ( Figure 1A ). In contrast, a more detailed analysis of lymphocyte subpopulations after specific staining with monoclonal antibodies revealed a significantly higher percentage of NK cells among lymphocytes of individuals with Down syndrome (median, 14.68%; interquartile range [IQR], 8.45%) compared with controls (8.10%; 6.92%; P < .001), whereas the percentage of B cells was significantly lower in Down syndrome (11.96%; 6.73%) than in controls (15.79%; 12.01%; P < .001; Figure 1B ). While the overall percentages of T cells did not differ between the groups ( Figure  1B ), individuals with Down syndrome had significantly lower levels of CD4 + T cells (median, 33.83%; IQR, 12.16%) than controls (38.74%; 10.54%; P = .01) and higher percentages of CD4 + CD8 + T cells (P < .01). No differences were observed in CD8 + T cells (P = .25; Figure 1C ). Given the lower percentage of CD4 + T cells among lymphocytes, CD4 + T-cell subpopulations were characterized in more detail ( Figure 1D -1F). Regulatory T cells were identified as CD25 + CD127 low CD4 + T cells, whereas Th1, Th2, and Th17 cells were quantified after polyclonal stimulation with SEB based on induction of IFN-γ, IL-4, or IL-17, respectively. Interestingly, median percentages of regulatory T cells were significantly higher in individuals with Down syndrome (median, 8.51%; IQR, 2.25%) as compared with controls (6.77%; 2.31%; P < .001). This also held true for Th1 and Th17 cells ( Figure 1D and 1E, P < .001), whereas the percentage of Th2 cells did not differ between the 2 groups ( Figure 1E ; P = .82). Consequently, individuals with Down syndrome showed a significantly higher Th1/Th2 ratio (median, 2.47%; IQR, 2.84%) than controls (1.48%; 2.27%; P = .03; Figure 1F ), which suggests a relative imbalance between proinflammatory and anti-inflammatory immune responses.
Because thymectomy is also known to influence lymphocyte subpopulations, results were stratified for individuals without or with partial or complete resection of the thymus. In general, thymectomy was associated with a lower percentage of T cells in both individuals with Down syndrome and controls (Supplementary Figure S1A) . When comparing nonthymectomized individuals, significant differences remained for B cells, NK cells, and CD4 + CD8 + and regulatory T cells (Supplementary Figure S1B-S1F). Among individuals with Down syndrome, thymectomy had a further increasing effect on regulatory T cells and was associated with higher Th2 levels (Supplementary Figure S2) .
Taken together, individuals with Down syndrome and controls show distinct differences in lymphocyte subpopulations with altered percentages of NK, B, and CD4 + T cells. Among CD4 + T cells, percentages of regulatory T cells, Th1, and Th17 cells were found to be higher.
Phenotypical Signs Associated With Anergy in Lymphocyte Subsets in Individuals With Down Syndrome
After assessment of quantitative differences in lymphocyte subsets, the median cell-surface expression of the anergy marker PD-1 was analyzed on bulk lymphocytes as well as on CD4 + , CD8 + , and regulatory T cells (Figure 2 ). Interestingly, individuals with Down syndrome showed a significantly higher expression of PD-1 not only on lymphocytes in general (Figure 2A ), but also on CD4 + T cells, CD8 + T cells, and regulatory T cells (all P < .001) ( Figure 2B-2D ). These effects were independent of thymectomy (data not shown). Taken together, our findings indicate that the main T-cell subsets, such as CD4 + , CD8 + , and regulatory T cells, show phenotypical signs associated with anergy in individuals with Down syndrome.
Higher Percentage of Effector T Cells in Individuals With Down Syndrome
Our observation that percentages of effector Th1 and Th17 cells were increased in individuals with Down syndrome prompted us to assess whether the increased PD-1 expression observed on bulk T cells also extended to effector CD4 + and CD8 + T cells and affected their activation status and functionality. Thus, effector CD4 + and CD8 + T cells from blood samples stimulated with SEB were quantified and characterized for expression of anergy markers and other cytokines. A representative dot plot of activated CD69 + IFN-γ + CD4 + T cells along with negative control stimulation from a child with Down syndrome is shown in Figure 3A . Unlike median percentages of SEB-reactive CD4 + T cells, which were significantly higher in individuals with Down syndrome, the percentage of SEB-reactive CD8 + T cells did not differ between the 2 groups ( Figure 3B) . Interestingly, the difference in SEB-reactive CD4 + T-cell levels emerged already within the first year of life and remained significant in all other age groups ( Figure 3C ). Because the quantitative differences were restricted to CD4 + T cells, IFN-γ-producing effector CD4 + T cells were further characterized for expression of the anergy markers PD-1 and CTLA-4. Of note, PD-1-and CTLA-4 expression on IFN-γ-producing effector CD4 + T cells did not differ between the 2 groups, whereas the remaining fraction of nonreactive CD4 + T cells had higher expression levels of the 2 molecules in individuals with Down syndrome ( Figure 3D ; see also Figure 2B ). The same held true for PD-1 expression on CD8 + T cells (data not shown). Thus, unlike bulk T cells, effector T cells in individuals with Down syndrome do not seem to exhibit phenotypical signs of anergy.
For further functional characterization of SEB-reactive effector CD4 + T cells, we performed simultaneous analysis of IFN-γ, TNF-α, and IL-2 . Figure 3E depicts representative dot plots of cytokine-producing CD4 + T cells. Boolean gating enabled discrimination of 7 subsets of cells with single-, double-, and triple-cytokine-producing capacities. As with increased levels of IFN-γ-producing CD4 + T cells (Figure 3B ), the median percentage of CD4 + T cells producing any of the 3 cytokines was significantly higher in individuals with Down syndrome ( Figure 3F ; median, 13.98%; IQR, 14.38%) than in controls (8.48%; 6.41%; P < .001), whereas the median expression levels of the 3 evaluated cytokines did not differ between the 2 groups (data not shown). Analysis of cytokine-producing subpopulations revealed that individuals with Down syndrome had a lower percentage of TNF-α single-producing cells and a concomitantly higher percentage of TNF-α/IL-2 double-producing cells and polyfunctional cells producing all 3 cytokines ( Figure 3G ). Taken together, despite the increased PD-1 expression on bulk T cells in individuals with Down syndrome, Differences between the 2 groups were calculated using the Mann-Whitney test. By comparing individuals with and without acute respiratory tract infection in both groups (CG and DS), we noted that our results were unaffected by acute respiratory tract infections; the only significant difference was a higher percentage of granulocytes in individuals with DS with acute respiratory tract infections than in those without (P = .02). *P < .05; †P < .01; ‡P < .001.
their effector T cells after polyclonal stimulation show unaltered phenotypical properties and only subtle differences in cytokine profiles, but the percentage of effector CD4 + T cells is significantly increased.
Normal Pathogen-Specific Immune Responses in Individuals With Down
Syndrome
After assessing polyclonally stimulated effector T cells, we next analyzed pathogen-specific cellular immune responses to CMV and VZV. Moreover, humoral immunity toward CMV and VZV was quantified as IgG antibody levels. Both groups showed a similar level of seropositivity for CMV and VZV (Figure 4) . Based on qualitative analysis, correlation of CMV-specific humoral and cellular immunity was strong in both individuals with Down syndrome (κ = 0.92) and controls (κ = 1.0; Figure 4A ). Only 1 CMV-seropositive child with Down syndrome showed a CMV-specific T-cell frequency of 0.044%, which was just marginally below the detection limit of 0.05%. Regarding VZV-specific immunity, correlation between cellular and humoral immunity was less pronounced and markedly higher in individuals with Down syndrome (κ = 0.77) than in controls (κ = 0.29; Figure 4B ). This difference was mainly due to the fact that a significantly higher percentage (20 of 22; 90.9%) of VZV-seropositive individuals with Down syndrome showed detectable cellular immunity, compared with the control group (22 of 38; 57.9%; P = .009). This does not seem to be due to the type of contact with VZV antigens, because the distribution of vaccinated individuals and those with a known history of VZV infection did not differ between the 2 groups (Table 1) .
We next compared CMV-and VZV-specific T-cell frequencies and respective antibody levels quantitatively in all seropositive individuals. Although the percentages of CD69 + IFN-γ + CMV-and VZV-specific effector T cells were higher in individuals with Down syndrome, this difference did not reach statistical significance. When reactive CD4 + T cells were analyzed for combined expression of IFN-γ, TNF-α, and IL-2, we observed a general difference in the cytokine expression profiles between CMV-and VZV-reactive cells, but not between individuals with Down syndrome and controls ( Figure 5B ). When we compared IgG antibody levels against CMV and VZV using enzymelinked immunosorbent assay ( Figure 5C ), individuals with Down syndrome had significantly higher median levels of CMV-specific IgG antibodies (167.1; IQR, 42.9) than controls (135.6; 45.5; P = .03), whereas VZV-specific IgG antibody levels did not differ between the 2 groups. Together both qualitative and quantitative analyses indicate that the ability to mount pathogen-specific humoral or cellular immunity does not seem to be impaired in individuals with Down syndrome.
DISCUSSION
This study was based on the epidemiological evidence that children with Down syndrome more frequently experience infectious episodes [3, 7, 8] , impaired responses after vaccination [13, 14, 22, 23] , and autoimmune diseases [22, [24] [25] [26] . IL-2) . F, The percentage of cells producing any of the cytokines is shown for both groups. G, Quantification of the percentage of cells producing 1, 2, or all 3 cytokines; this analysis was restricted to samples with ≥20 cytokine-positive cells (DS, n = 37; CG, n = 50) to ensure robust statistical analysis. In B-D and F, median and interquartile ranges are shown, and statistical analysis was performed using the Mann-Whitney test; data in G represent means and standard deviations, and statistical analysis of cytokine profiles was performed using the unpaired t test. *P < .05; †P < .01; ‡P < .001; NS, not significant.
Because knowledge on alterations in T-cell subpopulations and antigen-specific effector T-cell functionality is limited, we performed a detailed analysis of lymphocyte subpopulations and characterization of effector T cells in mainly pediatric individuals with Down syndrome and control subjects. In accordance with published evidence [9, [27] [28] [29] , we found normal levels of circulating CD8 + T cells, but an increased percentage of NK cells and decreased percentages of B and CD4 + T cells. Moreover, phenotypical analysis revealed a significantly increased expression of the inhibitory receptor PD-1 on T cells of all major subpopulations, including regulatory T cells, CD4 + and CD8 + T cells, which may suggest an increased turnover of memory T cells. In addition, the percentage of effector CD4 + T-cell subpopulations, such as Th1, Th17, and regulatory T cells, was increased, whereas levels of Th2 cells and effector CD8 + T cells did not differ from those in controls. Although individuals with Down syndrome had significantly higher expression levels of PD-1 and CTLA-4 on bulk CD4 + T cells than controls, the expression of these anergy markers on effector CD4 + T cells after stimulation did not differ between the 2 groups. Although our data are descriptive, this finding may indicate normal functionality, which is further supported by the fact that cytokine profiles of effector CD4 + T cells show only marginal differences from controls. Together, our results suggest that young individuals with Down syndrome are able to mount effector T-cell responses with normal phenotypical and functional characteristics, but one may speculate that an increased level of effector T cells is required to achieve protective immunity.
Alterations in lymphocyte subpopulations in children with Down syndrome have been attributed to an accelerated involution of the thymus and atrophy as observed in the elderly [15, 30, 31] , which may be further aggravated in children with partial or complete surgical resection of the thymus [3, [32] [33] [34] . Interestingly, most studies do not provide information on prior thymectomy to distinguish effects from Down syndrome and thymectomy. Although our study may seem limited by the fact that some children underwent thymus resection during corrective cardiac surgery of congenital heart defects, subgroup analysis of nonthymectomized individuals indicated that most observations were independent of surgical thymus resection.
In general, children with Down syndrome have fewer naive cells owing to decreased thymic output [15, 30, 31] , higher percentages of NK cells with reduced functionality [35] , and higher percentages of apoptotic lymphocytes [17, 18] . This has been interpreted as an immune profile of premature immunosenescence [9, [27] [28] [29] , which is further supported by our results. Among T cells, a decreased percentage was primarily found for CD4 + T cells, whereas CD8 + T-cell levels were rather similar to controls. However, the increased expression of inhibitory receptors on bulk CD4 + , CD8 + , and regulatory T cells of individuals with Down syndrome seems consistent with a dysregulated Percentages of children with immunoglobulin (Ig) G or T-cell immunity to CMV and VZV above the detection limit were determined. IgG levels were stratified as negative (−), positive (+), or intermediate (±) . The values represent the number of individuals in each group. Correlations were calculated using κ statistics. There were no significant differences in age when comparing CMV-and VZV-seropositive individuals. Among seropositive individuals, asterisks denote groups that include children <1 year old (1 in each group), that may be due to passive maternal antibodies. cellular immune system with some degree of functional anergy, because inhibitory receptors such as PD-1 or CTLA-4 are up-regulated in this situation [36] . Alternatively, the increased expression of these receptors may be a consequence of more frequent infection episodes. The decreased percentage of circulating B cells has been associated with a deficiency in B-cell development [12, 13] , which accounts for altered immunoglobulin expression characterized by lower IgM levels but IgG levels that are rather similar to or even higher than those of controls [9] . Among IgG antibodies, levels of the subtypes IgG1 and IgG3 are increased, whereas those of IgG2 and IgG4 are rather similar to those in controls [3] . This is consistent with our findings of an increased percentage of Th1 cells and normal Th2-cell levels, which provide help in stimulating IgG1/3 and IgG2/4, respectively. The higher Th1/Th2 ratio, also seen in adults [37] , suggests an unbalanced relation between anti-and proinflammatory immune responses, which may also favor the development of autoimmunity [22, 24, 25] . In addition, autoimmunity may more likely develop in the presence of decreased levels of regulatory T cells. However, against our expectations, individuals with Down syndrome showed increased regulatory T-cell levels, possibly compensating for decreased functionality, which is evident from higher PD-1 expression as a known phenotypical sign of anergy, and a reduced inhibitory potential on autologous effector T-cell proliferation in vitro [38] .
Among infections, children with Down syndrome show an increased susceptibility toward severe respiratory infections (ie, respiratory syncytial virus), which are mainly observed in the first years of life [7, 8] . Causes may be multifactorial. This susceptibility may be related to congenital heart disease, thymectomy, autoimmunity, cystic fibrosis, prematurity, neuromuscular disease, and/or abnormal anatomy of the airway, sinuses and Eustachian tubes [3, 7] . Moreover, immunological alterations, such as a lower percentage of B cells, may cause an increased incidence of infections [13, 15, 27] , which may also account for altered responses toward vaccinations [13, 14, 23] . As shown for primary influenza vaccination, children with Down syndrome had significantly fewer vaccine-induced IgG-producing B cells than controls [13] . In contrast, when the same children received a pneumococcal booster vaccination, the number of vaccine-induced IgG-producing B cells showed a significant increase, whereas no increase was observed in controls, presumably owing to a strong pre-existing immunity. Despite these differences in antibody-producing cells during primary vaccination, both groups reached similar vaccine efficacy as determined by specific serum antibody levels [13] . These data from B cells and humoral immunity suggest that children with Down syndrome may require repeated antigen-stimulation by recurrent natural infection or booster vaccination to reach an adequate level of immune protection. Similar mechanisms may apply for the induction of antigen-specific T cells during infection or vaccination. T-cell immunity toward CMV and VZV was similar in individuals with Down syndrome and controls, and CMV-specific cellular immunity showed a strong correlation with humoral immunity. In CMV-infected individuals, subclinical viral replication events are thought to contribute to life-long maintenance of CMV-specific T cells [39, 40] , whereas VZV-specific cellular immunity seems to wane in the absence of active viral replication [19] . This may explain the lower percentage of VZV-seropositive controls with detectable T cells. One may speculate that the higher percentage of individuals with Down syndrome with detectable VZV-specific T cells may result from more frequent boosts in cellular immunity due to subclinical replication events. As judged by effector CD4 + T cells after polyclonal or pathogen-specific stimulation, young individuals with Down syndrome can mount a specific T-cell immunity similar in phenotype and functionality to that seen in controls. Interestingly, however, the percentage of effector T cells is significantly increased, which may suggest a higher level of activation and/or expansion. As with antibody levels, the increase may be a consequence of prolonged antigen exposure during active infection, potentially due to a less efficient expansion of specific T cells with an anergic phenotype. Alternatively, one may speculate that the anergic phenotype of bulk T cells and the higher level of cells with apoptotic phenotype [17, 18] may be a consequence rather than a cause of differences in infection history and may indicate an increased turnover of effector T cells that have been shut down after recurring episodes of infections. At present, our data are descriptive, but given the known higher risk of respiratory infections in children with Down syndrome [7, 8] , it would be interesting to study the dynamics in the induction and functionality of antigen-specific T cells during and after episodes of respiratory infections.
In conclusion, our results extend current knowledge on the modulation of the immune response in children and adolescents with Down syndrome. Dysregulation not only affects B cells and humoral immunity but also has a quantitative and qualitative impact on T-cell-mediated immunity. As a practical consequence, recurrent infectious episodes in the first years of life may eventually boost natural humoral and cellular immunity to above protective levels, which may explain the decreasing incidence of infectious complications later in life. In terms of vaccination, where primary vaccination is frequently less efficient, this may imply the need for more frequent booster immunizations to ensure protective immunity in the long-term. Together, these findings may imply that differences in effector T-cell levels between children and adolescents with Down syndrome and controls may become less pronounced in older age groups, which may be an interesting area for future research.
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